Stay updated on Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer’s revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.0%
    Check dated 2026-11-02T15:50:10.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide NIH notice was added, announcing a transition from the term “Artificial Intelligence” to “Super Intelligence” and pointing visitors to updates and FAQs.
    Difference
    0.3%
    Check dated 2026-10-26T15:16:30.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T14:51:47.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The website footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-12T14:55:37.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    A new Revision: v3.7.0 entry was added to the history, and the previous Revision: v3.6.6 entry was removed, indicating a minor version update in the page's history log.
    Difference
    0.0%
    Check dated 2026-09-21T22:22:09.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    A new history entry on 2026-09-01 adds an update to the Study Status (version 78), and an entry from 2026-08-13 was removed. This documents a fresh status update and a historical cleanup in the trial's record history.
    Difference
    0.2%
    Check dated 2026-09-07T20:56:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.